KUALA LUMPUR,October 14 – Malaysian Genomics Resource Centre Berhad (“Malaysian Genomics” or “the Group”), a leading genomics and biopharmaceutical specialist, is excited to announce a Strategic Collaboration Agreement with Persatuan Pentas Anak Seni Malaysia (“PPASM”). This innovative partnership, set to take the spotlight at the upcoming Miss International Malaysia 2023 National Grand Final on October 1st, brings together the worlds of entertainment, arts, and culture with cutting-edge biopharmaceutical technologies.
These technologies include immunotherapy, CAR-T cells, Natural Killer (NK) cells, and MGRCH’s cosmeceutical products like hair serum, moisturizers, and face wash under their Rejuvium brand. PPASM will manage organizational aspects such as approvals and permits, while MGRCH contributes its top-tier expertise in immunotherapy and cell therapies. This collaboration aims not only to promote health awareness but also to create an environment where individuals are empowered to make informed health decisions.
Azri Azerai, Executive Chairman of Malaysian Genomics, expressed enthusiasm, stating, “Our alliance with PPASM offers a powerful blend of cultural outreach and advanced biopharmaceuticals, empowering Malaysians to take charge of their health. Investors should recognize this collaboration as a broadening of our market scope and a reiteration of our commitment to innovative healthcare solutions.” Jawed Hussain Bin Datuk Raman Wahid, President/National Director of PPASM, highlighted the importance of health in their line of work, saying, In this line of work, we will need to always be in the best shape to give the best of ourselves in our work and to the audience.
Working together with MGRC we can learn more about not just our health, but preventive healthcare as well. The partnership will commence with both parties actively organizing educational and promotional events. These will include online and offline campaigns that leverage the unique strengths of each partner. PPASM’s connections in the arts and culture sector, combined with MGRCH’s scientific proficiency, are expected to amplify the reach and impact of these health awareness campaigns.
This collaboration also has a charitable aspect, with net proceeds from the Miss International Malaysia 2023 event benefiting CSR initiatives such as the Sandakan Break Cancer Support Association, Kinabalu Pink Ribbon, and the Meraki Daat Sabah Initiative. This ensures that the collaboration not only raises awareness and educates the public but also has a tangible impact on charitable organizations working in similar domains.
In the spirit of September being Blood Cancer Awareness month, MGRCH recently collaborated with Yayasan Kanser Malaysia (“YKM”) to elevate cancer awareness and stress the importance of early detection within the community by utilizing MGRCH’s advanced genomic and immunotherapy services, including cutting-edge CAR-T cells and Natural Killer (NK) cells. As of September 8, 2023, MGRC’s share price stood at RM0.485, with a market capitalization of RM66.55 million. This collaboration signifies a promising step forward in merging healthcare and entertainment for the betterment of Malaysia’s health and well-being.
